|
業務類別
|
-- |
|
業務概覽
|
Japan Tobacco primarily sells cigarettes and reduced-risk products, organized in three clusters consisting of Asia (which includes its home market and countries in Asia Pacific), Western Europe, and EMA (which includes Eastern Europe, the Middle East North Africa, Turkey, Americas, and duty-free). Its leading cigarette brands include Winston (non-US), Camel (non-US), Mevius, and LD. Its reduced-risk brands include Logic in vaping, Ploom in heated tobacco, and Nordic Spirit in nicotine pouches, though these generates less than 5% of tobacco sales. |
| 公司地址
| 4-1-1 Toranomon, Minato-ku, Tokyo, JPN, 105-6927 |
| 電話號碼
| +81 366362914 |
| 傳真號碼
| +81 355721441 |
| 公司網頁
| https://www.jti.co.jp |
| 員工數量
| 59297 |
| Mr. Takehiko Tsutsui |
Director, President and Chief Executive Officer |
-- |
23/03/2026 |
| Mr. Kei Nakano |
Director and Executive Vice President, Finance, Corporate Communications, Business Development and D-LAB |
-- |
23/03/2026 |
| Mr. Koji Shimayoshi |
Director and Executive Vice President, Corporate Governance, Compliance, Corporate Strategy, Sustainability, People & Culture, Information Technology, Legal, Operation Review & Business Assurance, Pharmaceutical Business and Food Business |
-- |
23/03/2026 |
|
|
| Ms. Yukiko Uchida |
Independent Director |
23/03/2026 |
| Mr. Takehiko Tsutsui |
Director, President and Chief Executive Officer |
23/03/2026 |
| Mr. Tetsuya Shoji |
Independent Director |
23/03/2026 |
| Ms. Hiroko Yamashina |
Independent Director |
23/03/2026 |
| Mr. Masamichi Terabatake |
Deputy Chairman of the Board |
23/03/2026 |
| Mr. Masato Kitera |
Independent Director |
23/03/2026 |
| Mr. Shigeaki Okamoto |
Chairman of the Board |
23/03/2026 |
| Mr. Kei Nakano |
Director and Executive Vice President, Finance, Corporate Communications, Business Development and D-LAB |
23/03/2026 |
| Mr. Kenji Asakura |
Independent Director |
23/03/2026 |
| Mr. Koji Shimayoshi |
Director and Executive Vice President, Corporate Governance, Compliance, Corporate Strategy, Sustainability, People & Culture, Information Technology, Legal, Operation Review & Business Assurance, Pharmaceutical Business and Food Business |
23/03/2026 |
|
|
|
|
